Géraldine Teppaz

Title: Géraldine Teppaz: Innovator in T Cell Response Enhancement

Introduction

Géraldine Teppaz is a notable inventor based in St. Herblain, France. He has made significant contributions to the field of immunology, particularly in enhancing T cell responses. His innovative work has led to the development of a patent that addresses critical aspects of T cell activation and response.

Latest Patents

Géraldine Teppaz holds a patent titled "Methods for promoting T cells response by administering an antagonist of human c-type lectin-like receptor 1 (CLEC-1)." This invention focuses on methods for promoting T cell responses by examining the expression and function of CLEC-1 in human dendritic cells (DCs). The research demonstrated the cell-surface expression of CLEC-1 and its functional role in orchestrating T cell responses. The findings showed that disrupting CLEC-1 signaling enhances Th17 activation and improves T cell priming and activation of both Th17 and Th1 cells in vitro and in vivo.

Career Highlights

Throughout his career, Géraldine Teppaz has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Nantes. His research has significantly advanced the understanding of T cell biology and the potential therapeutic applications of CLEC-1 antagonists.

Collaborations

Géraldine has collaborated with notable colleagues, including Elise Chiffoleau and Nicolas Poirier. Their joint efforts have contributed to the successful exploration of T cell responses and the development of innovative therapeutic strategies.

Conclusion

Géraldine Teppaz is a pioneering inventor whose work in enhancing T cell responses has the potential to impact immunotherapy significantly. His contributions to the field of immunology are noteworthy and continue to inspire further research and innovation.